HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
The purpose of this study is to determine the safety and tolerability of an experimental form of therapy, known as WU-CART-007 (“study drug”).
The Teachey Lab studies signal transduction disruptions in leukemic cells to identify targeted cancer inhibitors and immunotherapies to treat high-risk leukemias and autoimmune lymphoproliferative syndrome.
